Clinical Trials · NCT07430332

GLP-1 RA for Stage 1 Type 1 Diabetes

Not Yet RecruitingPhase 2Semaglutide (Investigational)
Phase
Phase 2
Recruitment status
Not Yet Recruiting
Sponsor
Children's Hospital Medical Center, Cincinnati
Enrollment
15
Start date
Sep 2027
Locations
1 site, United States
Primary endpoint
C-peptide area under the curve
View Semaglutide compound reference